Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference
September 04, 2024 16:05 ET
|
Sensei Biotherapeutics
BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation...
Sensei Biotherapeutics to Present at Upcoming Conferences
September 04, 2024 07:30 ET
|
Sensei Biotherapeutics
BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation...
BJ’s Restaurants, Inc. Announces Appointment of President & Chief Concept Officer
September 03, 2024 11:25 ET
|
BJ's Restaurants, Inc.
HUNTINGTON BEACH, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (Nasdaq: BJRI) (“BJ’s” or the “Company”) announced today that Lyle D. Tick, former Brand President of Buffalo Wild...
Music Licensing, Inc. (OTC: SONG) anuncia aquisição de direitos autorais de “Thank God I Got It” de Desiigner, reforçando seu portfólio diversificado e repleto de estrelas
September 03, 2024 09:25 ET
|
Music Licensing, Inc.
NAPLES, Flórida, Sept. 03, 2024 (GLOBE NEWSWIRE) -- A Music Licensing, Inc. (OTC: SONG), uma entidade líder na indústria musical, tem o prazer de anunciar a aquisição dos direitos autorais de...
Crown Electrokinetics Issues Letter to Shareholders
September 03, 2024 08:15 ET
|
Crown Electrokinetics Corp.
LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber...
Congreso ESC 2024: El ensayo INFINITY-SWEDEHEART del bioadaptador DynamX de Elixir Medical alcanza el criterio de valoración principal y los resultados clínicos confirman su exclusivo mecanismo de acción
September 02, 2024 07:45 ET
|
Elixir Medical Corporation
Congreso ESC 2024: El ensayo INFINITY-SWEDEHEART del bioadaptador DynamX de Elixir Medical alcanza el criterio de valoración principal y los resultados clínicos confirman su exclusivo mecanismo de...
Congresso ESC 2024: lo studio INFINITY-SWEDEHEART relativo al DynamX Bioadaptor di Elixir Medical soddisfa l’endpoint primario e i risultati clinici confermano un meccanismo d’azione unico
September 02, 2024 07:45 ET
|
Elixir Medical Corporation
Congresso ESC 2024: lo studio INFINITY-SWEDEHEART relativo al DynamX Bioadaptor di Elixir Medical soddisfa l’endpoint primario e i risultati clinici confermano un meccanismo d’azione unico — La più...
BJ’s Restaurants, Inc. Announces Upcoming Senior Management Transition
August 28, 2024 16:01 ET
|
BJ's Restaurants, Inc.
HUNTINGTON BEACH, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (Nasdaq: BJRI) (“BJ’s” or the “Company”) announced today that C. Bradford (“Brad”) Richmond, current BJ’s Board...
BJ’s Restaurants Opens in Tracy, California
August 27, 2024 13:15 ET
|
BJ's Restaurants, Inc.
HUNTINGTON BEACH, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced the opening of its restaurant in Tracy, California. The new BJ’s Restaurant &...
BJ’s Restaurants, Inc. to Participate at the Piper Sandler Growth Frontiers Conference
August 27, 2024 13:00 ET
|
BJ's Restaurants, Inc.
HUNTINGTON BEACH, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) announced today that management will be participating at the Piper Sandler Growth Frontiers...